Dengue vaccine study for children and teens
Part of Infections clinical trials.
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child or teen eligible for the dengue vaccine in your area.
- Your family plans to stay in the same hospital area for at least 3 years.
- One parent or guardian must sign a consent form, and you must sign an age-appropriate agreement form.
- You agree to a baseline blood test.
- You have not already received a dengue vaccine (TDV, CYD-TDV, or any other study dengue vaccine).
- There are no medical reasons that would make the vaccine unsafe for you (as listed in the product label).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
This trial tests a two-dose dengue vaccine compared to the standard one-dose vaccine in children and teens who have never had dengue. It checks if the two-dose version works better and if a new manufacturing version works the same.
This trial tests a new dengue vaccine in adults aged 40 to 79 to see if it can protect them from dengue fever. If you are generally healthy and willing to follow the study schedule, you may be able to join.
This study looks at how the dengue vaccine works in people with and without past exposure to dengue or similar viruses like yellow fever or Zika. Volunteers receiving the dengue vaccine will give blood samples to help researchers understand the immune response.
This trial looks at a dengue vaccine strategy in children ages 9 to 17 in Martinique and Guadeloupe. It may help protect kids from dengue, based on how the vaccine is accepted and how the study is carried out.
This study collects blood samples from people with suspected or confirmed dengue to help improve testing. Participation may help researchers understand the disease better and could lead to better diagnostics.
Hear when a new Dengue Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.